98 related articles for article (PubMed ID: 28273003)
1. Male engagement in women's microbicide use in Kenya: Navigating gender norms.
Schuler SR; Bukusi E
Health Care Women Int; 2017 May; 38(5):507-519. PubMed ID: 28273003
[TBL] [Abstract][Full Text] [Related]
2. Engaging male partners in women's microbicide use: evidence from clinical trials and implications for future research and microbicide introduction.
Lanham M; Wilcher R; Montgomery ET; Pool R; Schuler S; Lenzi R; Friedland B
J Int AIDS Soc; 2014; 17(3 Suppl 2):19159. PubMed ID: 25224618
[TBL] [Abstract][Full Text] [Related]
3. Male Partner Influence on Women's HIV Prevention Trial Participation and Use of Pre-exposure Prophylaxis: the Importance of "Understanding".
Montgomery ET; van der Straten A; Stadler J; Hartmann M; Magazi B; Mathebula F; Laborde N; Soto-Torres L
AIDS Behav; 2015 May; 19(5):784-93. PubMed ID: 25416076
[TBL] [Abstract][Full Text] [Related]
4. To tell or not to tell: male partner engagement in a Phase 3 microbicide efficacy trial in South Africa.
Kelly CA; Friedland BA; Morar NS; Katzen LL; Ramjee G; Mokgatle MM; Ahmed K
Cult Health Sex; 2015; 17(8):1004-20. PubMed ID: 25913101
[TBL] [Abstract][Full Text] [Related]
5. Optimizing HIV prevention for women: a review of evidence from microbicide studies and considerations for gender-sensitive microbicide introduction.
Doggett EG; Lanham M; Wilcher R; Gafos M; Karim QA; Heise L
J Int AIDS Soc; 2015; 18(1):20536. PubMed ID: 26700845
[TBL] [Abstract][Full Text] [Related]
6. Prevention, Partners, and Power Imbalances: Women's Views on How Male Partners Affected Their Adherence to Vaginal Microbicide Gels During HIV Prevention Trials in Africa.
Miller L; Morar N; Kapiga S; Ramjee G; Hayes R
J Acquir Immune Defic Syndr; 2020 Dec; 85(4):458-465. PubMed ID: 33136745
[TBL] [Abstract][Full Text] [Related]
7. Communicating about microbicides with women in mind: tailoring messages for specific audiences.
Sidibe S; Pack AP; Tolley EE; Ryan E; Mackenzie C; Bockh E; Githuka G
J Int AIDS Soc; 2014; 17(3 Suppl 2):19151. PubMed ID: 25224612
[TBL] [Abstract][Full Text] [Related]
8. Educating men about vaginal microbicides: considerations from Kenya.
Gitome SW; Kwena ZA; Harper CC; Cohen CR; Bukusi EA
Cult Health Sex; 2020 Jun; 22(6):660-674. PubMed ID: 31241426
[TBL] [Abstract][Full Text] [Related]
9. Sexuality, HIV risk and potential acceptability of involving adolescent girls in microbicide research in Kisumu, Kenya.
Montandon M; Sahin-Hodoglugil NN; Bukusi E; Agot K; Boland B; Cohen CR
Sex Health; 2008 Dec; 5(4):339-46. PubMed ID: 19061553
[TBL] [Abstract][Full Text] [Related]
10. The role of partnership dynamics in determining the acceptability of condoms and microbicides.
Montgomery CM; Lees S; Stadler J; Morar NS; Ssali A; Mwanza B; Mntambo M; Phillip J; Watts C; Pool R
AIDS Care; 2008 Jul; 20(6):733-40. PubMed ID: 18576176
[TBL] [Abstract][Full Text] [Related]
11. Pregnant young women's attitudes about microbicides: the anticipated influence of the grandmother and father of the baby on microbicide use.
Francis JKR; Fraiz LD; Catallozzi M; deRoche AM; Mauro C; Rosenthal SL
Sex Health; 2017 Nov; 14(6):581-583. PubMed ID: 28514991
[TBL] [Abstract][Full Text] [Related]
12. Interest in using rectal microbicides among Australian gay men is associated with perceived HIV vulnerability and engaging in condomless sex with casual partners: results from a national survey.
Murphy DA; Lea T; de Wit JB; Ellard JM; Kippax SC; Rosengarten M; Holt M
Sex Transm Infect; 2015 Jun; 91(4):266-8. PubMed ID: 25416839
[TBL] [Abstract][Full Text] [Related]
13. Communication About Microbicide Use Between Couples in KwaZulu-Natal, South Africa.
Gafos M; Pool R; Mzimela MA; Ndlovu HB; McCormack S; Elford J;
AIDS Behav; 2015 May; 19(5):832-46. PubMed ID: 25488170
[TBL] [Abstract][Full Text] [Related]
14. Acceptability of vaginal microbicides among female sex workers and their intimate male partners in two Mexico-US border cities: a mixed methods analysis.
Robertson AM; Syvertsen JL; Martinez G; Rangel MG; Palinkas LA; Stockman JK; Ulibarri MD; Strathdee SA
Glob Public Health; 2013; 8(5):619-33. PubMed ID: 23398385
[TBL] [Abstract][Full Text] [Related]
15. The influence of social constructs of hegemonic masculinity and sexual behaviour on acceptability of vaginal microbicides in Zambia.
Mweemba O; Dixey R; Bond V; White A
Glob Public Health; 2018 Jul; 13(7):931-943. PubMed ID: 28604240
[TBL] [Abstract][Full Text] [Related]
16. 'The study has taught me to be supportive of her': empowering women and involving men in microbicide research.
Venables E; Stadler J
Cult Health Sex; 2012; 14(2):181-94. PubMed ID: 22085043
[TBL] [Abstract][Full Text] [Related]
17. Perspectives on biomedical HIV prevention options among women who inject drugs in Kenya.
Bazzi AR; Yotebieng KA; Agot K; Rota G; Syvertsen JL
AIDS Care; 2018 Mar; 30(3):343-346. PubMed ID: 28780885
[TBL] [Abstract][Full Text] [Related]
18. Women and ARV-based HIV prevention - challenges and opportunities.
Geary CW; Bukusi EA
J Int AIDS Soc; 2014; 17(3 Suppl 2):19356. PubMed ID: 25224621
[TBL] [Abstract][Full Text] [Related]
19. Muslim women's reflections on the acceptability of vaginal microbicidal products to prevent HIV infection.
Hoel N; Shaikh S; Kagee A
Ethn Health; 2011 Apr; 16(2):89-106. PubMed ID: 21328113
[TBL] [Abstract][Full Text] [Related]
20. Perceptions of acceptability and utility of microbicides in Ghana, West Africa: a qualitative, exploratory study.
Tanner AE
SAHARA J; 2008 Apr; 5(1):11-8. PubMed ID: 18496615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
